BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18707868)

  • 1. A diagnostic model to detect silent brain metastases in patients with non-small cell lung cancer.
    Na II; Lee TH; Choe DH; Cheon GJ; Kim CH; Koh JS; Baek H; Ryoo BY; Yang SH; Lee JC
    Eur J Cancer; 2008 Nov; 44(16):2411-7. PubMed ID: 18707868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma.
    Bajard A; Westeel V; Dubiez A; Jacoulet P; Pernet D; Dalphin JC; Depierre A
    Lung Cancer; 2004 Sep; 45(3):317-23. PubMed ID: 15301872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer.
    Wang SY; Ye X; Ou W; Lin YB; Zhang BB; Yang H
    Lung Cancer; 2009 May; 64(2):238-43. PubMed ID: 18838190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necessity of preoperative screening for brain metastasis in non-small cell lung cancer patients without lymph node metastasis.
    Yohena T; Yoshino I; Kitajima M; Uehara T; Kanematsu T; Teruya T; Ikeda J; Ichinose Y
    Ann Thorac Cardiovasc Surg; 2004 Dec; 10(6):347-9. PubMed ID: 15658906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study.
    Papotti M; Kalebic T; Volante M; Chiusa L; Bacillo E; Cappia S; Lausi P; Novello S; Borasio P; Scagliotti GV
    J Clin Oncol; 2006 Oct; 24(30):4818-24. PubMed ID: 17050866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging lung cancer.
    Patz EF
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):21-6. PubMed ID: 10566607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-small cell lung cancer and silent brain metastasis. Survival and prognostic factors.
    Sánchez de Cos J; Sojo González MA; Montero MV; Pérez Calvo MC; Vicente MJ; Valle MH
    Lung Cancer; 2009 Jan; 63(1):140-5. PubMed ID: 18556086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing intracranial metastasis detection for stereotactic radiosurgery.
    Engh JA; Flickinger JC; Niranjan A; Amin DV; Kondziolka DS; Lunsford LD
    Stereotact Funct Neurosurg; 2007; 85(4):162-8. PubMed ID: 17259753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How can metastatic extension be assessed in the brain?].
    Baleriaux D; Lemort M
    Rev Mal Respir; 1992; 9 Suppl 4():R277-80. PubMed ID: 1336873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lung cancer in women: clinical features and factors related to survival].
    Sen E; Kaya A; Erol S; Savas I; Gonullu U
    Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy.
    Sekine I; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
    Lung Cancer; 2009 Aug; 65(2):219-22. PubMed ID: 19081161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI).
    Seute T; Leffers P; ten Velde GP; Twijnstra A
    Cancer; 2008 Apr; 112(8):1827-34. PubMed ID: 18311784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The correlation between the distant metastases and organ-specific symptoms in the patients with lung cancer].
    Alpar S; Uçar N; Turgut A; Kiratli T; Dursun BA; Kurt B
    Tuberk Toraks; 2004; 52(1):14-8. PubMed ID: 15143367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of metachronous brain metastases by biannual brain MRI follow-up may provide patients with non-small cell lung cancer with more opportunities to have radiosurgery.
    Nishikawa T; Ueba T; Kawashima M; Kajiwara M; Iwata R; Kato M; Miyamatsu N; Yamashita K
    Clin Neurol Neurosurg; 2010 Nov; 112(9):770-4. PubMed ID: 20621414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silent radiological imaging time in patients with brain metastasis.
    Mystakidou K; Boviatsis EJ; Kouyialis AT; Voumvourakis K; Kouloulias V; Kouvaris J; Vlahos L
    Clin Neurol Neurosurg; 2004 Sep; 106(4):300-4. PubMed ID: 15297004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100beta as a predictor of brain metastases: brain versus cerebrovascular damage.
    Vogelbaum MA; Masaryk T; Mazzone P; Mekhail T; Fazio V; McCartney S; Marchi N; Kanner A; Janigro D
    Cancer; 2005 Aug; 104(4):817-24. PubMed ID: 15971200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases.
    Oh Y; Taylor S; Bekele BN; Debnam JM; Allen PK; Suki D; Sawaya R; Komaki R; Stewart DJ; Karp DD
    Cancer; 2009 Jul; 115(13):2930-8. PubMed ID: 19441110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases.
    Hsiao SH; Chung CL; Chou YT; Lee HL; Lin SE; Liu HE
    Lung Cancer; 2013 Nov; 82(2):319-23. PubMed ID: 24018025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT, positron emission tomography, and MRI in staging lung cancer.
    Erasmus JJ; Sabloff BS
    Clin Chest Med; 2008 Mar; 29(1):39-57, v. PubMed ID: 18267183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign.
    Balekian AA; Fisher JM; Gould MK
    Chest; 2016 Apr; 149(4):943-50. PubMed ID: 26356134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.